HKD 0.11
(10.0%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 292 Million CNY | 7.94% |
2022 | 270.53 Million CNY | -8.51% |
2021 | 295.69 Million CNY | -3.3% |
2020 | 305.79 Million CNY | -0.51% |
2019 | 307.37 Million CNY | 11.11% |
2018 | 276.63 Million CNY | 3.44% |
2017 | 267.44 Million CNY | -9.75% |
2016 | 296.33 Million CNY | 4.68% |
2015 | 283.1 Million CNY | 27.37% |
2014 | 222.26 Million CNY | 11.98% |
2013 | 198.49 Million CNY | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q1 | 55.22 Million CNY | -37.76% |
2024 Q2 | 55.22 Million CNY | 0.0% |
2023 Q3 | 74.85 Million CNY | 19.97% |
2023 Q2 | 62.39 Million CNY | -5.49% |
2023 FY | 292 Million CNY | 7.94% |
2023 Q1 | 66.01 Million CNY | -21.72% |
2023 Q4 | 88.74 Million CNY | 18.55% |
2022 Q2 | 55.19 Million CNY | -7.58% |
2022 FY | 270.53 Million CNY | -8.51% |
2022 Q3 | 71.28 Million CNY | 29.14% |
2022 Q1 | 59.72 Million CNY | -34.25% |
2022 Q4 | 84.33 Million CNY | 18.31% |
2021 Q1 | 68.25 Million CNY | -28.07% |
2021 FY | 295.69 Million CNY | -3.3% |
2021 Q4 | 90.83 Million CNY | 18.87% |
2021 Q3 | 76.41 Million CNY | 26.97% |
2021 Q2 | 60.18 Million CNY | -11.83% |
2020 Q1 | 52.57 Million CNY | -43.04% |
2020 Q3 | 75.44 Million CNY | -8.97% |
2020 Q2 | 82.87 Million CNY | 57.64% |
2020 FY | 305.79 Million CNY | -0.51% |
2020 Q4 | 94.9 Million CNY | 25.79% |
2019 Q3 | 80.12 Million CNY | 21.03% |
2019 Q2 | 66.2 Million CNY | -3.69% |
2019 Q1 | 68.73 Million CNY | -18.96% |
2019 FY | 307.37 Million CNY | 11.11% |
2019 Q4 | 92.3 Million CNY | 15.2% |
2018 FY | 276.63 Million CNY | 3.44% |
2018 Q2 | 52.1 Million CNY | -25.03% |
2018 Q3 | 70.21 Million CNY | 34.77% |
2018 Q1 | 69.49 Million CNY | -13.12% |
2018 Q4 | 84.82 Million CNY | 20.8% |
2017 Q3 | 79.87 Million CNY | 38.61% |
2017 Q2 | 57.62 Million CNY | 15.38% |
2017 Q1 | 49.94 Million CNY | -52.84% |
2017 FY | 267.44 Million CNY | -9.75% |
2017 Q4 | 79.98 Million CNY | 0.14% |
2016 FY | 296.33 Million CNY | 4.68% |
2016 Q4 | 105.91 Million CNY | 45.92% |
2016 Q3 | 72.58 Million CNY | 20.3% |
2016 Q1 | 57.5 Million CNY | -37.72% |
2016 Q2 | 60.33 Million CNY | 4.92% |
2015 FY | 283.1 Million CNY | 27.37% |
2015 Q4 | 92.33 Million CNY | 15.23% |
2015 Q2 | 49.89 Million CNY | 0.0% |
2015 Q3 | 80.13 Million CNY | 60.61% |
2014 FY | 222.26 Million CNY | 11.98% |
2013 FY | 198.49 Million CNY | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Natural Beauty Bio-Technology Limited | 336.01 Million HKD | 13.096% |
Innovative Pharmaceutical Biotech Limited | 6.59 Million HKD | -4329.076% |
China Overseas Nuoxin International Holdings Limited | 180.99 Million HKD | -61.335% |
Prosperous Future Holdings Limited | 470.33 Million HKD | 37.914% |
Huasheng International Holding Limited | 565.9 Million HKD | 48.4% |
Fourace Industries Group Holdings Limited | 268.02 Million HKD | -8.949% |
Evergreen Products Group Limited | 979.24 Million HKD | 70.18% |
EC Healthcare | 4.21 Billion HKD | 93.066% |
Ming Fai International Holdings Limited | 2.06 Billion HKD | 85.875% |
Blue Moon Group Holdings Limited | 7.32 Billion HKD | 96.013% |
SuperRobotics Holdings Limited | 15.08 Million HKD | -1836.271% |
Takbo Group Holdings Limited | 215.59 Million HKD | -35.446% |
Hyfusin Group Holdings Limited | 866.25 Million HKD | 66.29% |